Volume 25, Number 3—March 2019
CME ACTIVITY - Synopsis
Bacillus Calmette-Guérin Cases Reported to the National Tuberculosis Surveillance System, United States, 2004–2015
Table 1
Characteristic | BCG cases, no. (%) | TB cases, no. (%) |
---|---|---|
Total cases reported, no. (%) | 118 (100) | 91,065 (100) |
Median age (interquartile range), y |
75 (66–81) |
47 (31–62) |
Age group, y | ||
0–4 | 6 (5) | 954 (1) |
5–14 | 0 | 856 (0.9) |
15–24 | 2 (2) | 10,398 (11) |
25–44 | 3 (3) | 30,236 (33) |
45–64 | 16 (14) | 28,327 (31) |
>65 |
91 (77) |
20,289 (22) |
Sex | ||
M | 110 (93) | 56,800 (62) |
F |
8 (7) |
34,265 (38) |
White, non-Hispanic | 95 (81) | 14,330 (16) |
US-born |
101 (86) |
35,215 (38.7) |
Pulmonary disease only | 15 (13) | 67,033 (74) |
Extrapulmonary disease only | 98 (83) | 14,659 (16) |
Both pulmonary and extrapulmonary disease |
5 (4) |
9,336 (10) |
Extrapulmonary sites of disease† | ||
Bones and joints | 37 (36) | 2,953 (12) |
Genitourinary | 30 (29) | 1435 (6) |
Lymphatic system | 4 (4) | 9,088 (38) |
Peritoneal | 4 (4) | 1,473 (6) |
Pleural | 3 (3) | 5,428 (3) |
Meningeal | 0 | 1,203 (5) |
Other extrapulmonary sites‡ |
30 (29) |
3,453 (14) |
History of long-term care facility residency | 11 (9) | 1,988 (2) |
Diabetes§ | 15 (21) | 7,864 (17) |
*BCG, Bacillus Calmette-Guérin; TB, tuberculosis.
†Denominators for percentages are based on the preceding 2 rows of all cases with any extrapulmonary involvement (i.e., with or without pulmonary involvement).
‡Include blood, urinary bladder, subcutaneous tissues, and bone marrow.
§Diabetes comorbidity data only available starting in 2009; therefore, percentages are based on different denominators (45,786 TB cases and 72 BCG cases).
Page created: February 19, 2019
Page updated: February 19, 2019
Page reviewed: February 19, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.